• "Schizotaxia": clinical implications and new directions for research
• A review of neuroimaging studies of young relatives of individuals with schizophrenia: a developmental perspective from schizotaxia to schizophrenia
• An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention
• Are neurocognitive, clinical and social dysfunctions in schizotaxia reversible pharmacologically?: Results from the Changsha study
• Carving nature at its joints: Paul Meehl's development of taxometrics
• Children at risk for schizophrenia: the Jerusalem Infant Development Study. II. Neurobehavioral deficits at school age
• Conceptualization of the liability for schizophrenia: clinical implications
• Concurrent validation of schizotaxia: a pilot study
• Developing a combined predictor measure for early detection of psychosis proneness
• Development of liability syndromes for schizophrenia: where did they come from and where are they going?
• Dimensionality vs taxonicity of schizotypy: some new data and challenges ahead
• Discerning the latent structure of hypothetical psychosis proneness through admixture analysis
• Early diagnosis of schizophrenic psychosis
• Generalized cognitive impairment in male adolescents with schizotypal personality disorder
• Genes, environment and schizophrenia
• Genetic markers for schizotaxia
• Long-term administration of the low-dose risperidone in schizotaxia subjects
• Minor physical anomalies and schizophrenia: literature review
• Moderately Eccentric: Evidence for Dimensionality in the Latent Structure of Schizotypal Personality Features
• Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia
• Pathways from developmental vulnerabilities in early childhood to schizotypy in middle childhood
• Prediction of Neurocognitive Deficits by Parkinsonian Motor Impairment in Schizophrenia: A Study in Neuroleptic-Naïve Subjects, Unaffected First-Degree Relatives and Healthy Controls From an Indigenous Population
• Prevention of schizophrenia
• Schizophrenia: family studies and treatment of spectrum disorders
• Schizophrenia: vulnerability versus disease
• Schizotaxia revisited
• Schizotaxia revisited: model issues in the etiology of schizophrenia
• Schizotaxia--theoretical construct or a tool for clinical research?
• Schizotaxia, information processing and the MMPI 2-7-8 code type
• Schizotaxia, schizotypy, and schizophrenia: Paul E. Meehl's blueprint for the experimental psychopathology and genetics of schizophrenia
• Schizotaxia: current status and future directions
• Searching for the liability to schizophrenia: concepts and methods underlying genetic high-risk studies of adolescents
• Self-centrality, psychosis and schizotaxia: a conceptual review
• Subjective experience of schizotropic vulnerability in siblings of schizophrenics
• The genetic and environmental basis of the relationship between schizotypy and personality: a twin study
• The genetics of schizophrenia
• The latent structure and coincidence of hypohedonia and schizotypy and their validity as indices of psychometric risk for schizophrenia
• The silent side of the spectrum: schizotypy and the schizotaxic self
• Thought disorder in offspring of schizophrenic parents: findings from the New York High-Risk Project
• Toward reformulating the diagnosis of schizophrenia
• Towards the prevention of schizophrenia
• Understanding predisposition to schizophrenia: toward intervention and prevention
• Validating schizotaxia and its place in studies of preventing schizophrenia by psychopharmacological intervention